ARCT — Arcturus Therapeutics Holdings Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall CapMomentum Trap
- $389.98m
- $212.04m
- $12.36m
Annual income statement for Arcturus Therapeutics Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 13 | 15.8 | 20.8 | 9.54 | 12.4 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 23.5 | 37.6 | 46.3 | 81.1 | 215 |
| Operating Profit | -10.5 | -21.8 | -25.5 | -71.5 | -203 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -10.9 | -21.8 | -26 | -72.1 | -204 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -10.9 | -21.8 | -26 | -72.1 | -204 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -10.9 | -21.8 | -26 | -72.1 | -204 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -10.9 | -21.8 | -26 | -72.1 | -204 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -3.53 | -2.16 | -2.15 | -3.55 | -7.74 |